Cryoablation Of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According To Study Presented At RSNA

Early clinical experience with the FDA cleared Visica 2(TM) Treatment System from Sanarus Medical confirms the effectiveness of ultrasound guided cryoablation to completely eradicate small, unifocal Invasive Ductal Breast Cancer (IDC). Initial data from this multi-center study was presented at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 29 - December 5, 2008.

More: continued here

Filed under: Breast Cancer on December 11th, 2008